Biomedical

Plymouth University is constructing the $22 million Derriford Research Facility at Plymouth Science Park in the United Kingdom. Housing advanced biomedical laboratories for the Peninsula Schools of Medicine and Dentistry, the 25,000-sf project will support clinical collaboration with the adjacent Derriford Hospital for the development of translational therapies. The facility will accommodate research on infectious diseases including Ebola and bovine TB as well as conditions such as Alzheimer's Disease, Parkinson's disease, and cancer.

Columbia University is building the 450,000-sf Jerome L. Greene Science Center in New York City. Designed by Renzo Piano, the interdisciplinary facility will promote creative collaboration among scientists with inviting interaction areas and laboratories arranged in connected quadrants. The Greene Science Center is the first structure on Columbia's 17-acre Manhattanville campus and is funded in part by a $250 million donation.

Mercer University School of Medicine dedicated an $18 million expansion of its Savannah campus in April of 2016. Located adjacent to Memorial University Medical Center, the project included renovation of 26,500 sf in the Hoskins Center for Biomedical Research and construction of a 30,000-sf addition. The completed facility provides research labs, classrooms, offices, exam rooms for clinical training, simulation suites, tutorial rooms, and study spaces.

EMD Serono broke ground in May of 2016 on a $12 million expansion of its biopharmaceutical manufacturing campus in Billerica, Mass. Accommodating 120 employees, the two-story, 30,000-sf facility will support the development of advanced therapies for the treatment of cancer and immunological conditions. The project will be constructed as an extension of the existing Sagamore Building and will feature open-plan work areas, a central auditorium, and numerous meeting spaces, including bleacher seating for spontaneous collaboration and interaction.

The University of California, San Francisco is planning to build the Weill Institute for Neurosciences on its Mission Bay campus. The facility will provide both research laboratories and clinical space, and is supported by a donation of $185 million by Sanford and Joan Weill. Accommodating 45 principal investigators, the collaborative project will integrate the disciplines of neurology, neuroscience, genomics, chemistry, computer science, psychiatry, and engineering.

Roswell Park Cancer Institute completed construction in April of 2016 on the $50.5 million Clinical Sciences Center in Buffalo, N.Y. Designed by FXFowle Architects, the 11-story, 142,000-sf project features an expanded chemotherapy clinic, a women's health center, research space, and patient care clinics. The facility also houses academic and administrative offices for physicians, researchers, and staff. The Clinical Sciences Center is located on the Buffalo Niagara Medical Campus and was built by LeChase Construction.

Coventry University is constructing the $52 million Science and Health Building in the United Kingdom. The five-story multidisciplinary facility will provide classrooms, simulation training suites, science labs, and core research space for the Faculty of Health and Life Sciences. The 121,200-gsf (75,500-nsf) project is being built by BAM Construction. Completion is expected by fall of 2017.

WuXi PharmaTech will begin construction in spring of 2015 on a 145,000-sf cGMP facility in Philadelphia. The project is expected to be operational by mid-2016 and will support the manufacture of cell therapy products for personalized medicine, including chimeric antigen receptor T cells.

Oregon Health & Sciences University began construction in January of 2016 on the $349 million Center for Health and Healing South in Portland, Ore. Designed by ZGF Architects and built by Hoffman Construction, the project includes a 14-story medical building and a 10-story mixed-use facility. The $160 Knight Cancer Institute will also be built on the South Waterfront Campus.

The National Veterinary Research Institute has completed commissioning the Bio-Safety Level III Laboratory in Vom, Nigeria. The $2.5 million facility will enhance the Institute's ability to detect, diagnose, and respond to infectious diseases throughout West Africa. The duration of construction for the project, which was created in partnership with the Canadian Department of Foreign Affairs and International Trade, was three years.

Novartis and the University of Pennsylvania Perelman School of Medicine celebrated the opening of the $27 million Center for Advanced Cellular Therapeutics in February of 2016 in Philadelphia. Accommodating the production of personalized cancer treatments using chimeric antigen receptor technology, the 30,000-sf facility features 23,610 sf of laboratory and cell therapy manufacturing space as well as a 6,300-sf cleanroom.

Alnylam Pharmaceuticals broke ground in April of 2016 on a $200 million manufacturing plant in Norton, Mass. Featuring RNA synthesis technologies with advanced purification methods, the 200,000-sf facility will accommodate up to 220 workers engaged in the production of innovative therapeutic agents. Jacobs Engineering Group will provide engineering and procurement services for the project. Completion is expected in 2018.

The University of East Anglia began site work in February of 2016 on the $140 million Quadram Institute, a new biomedical research facility located in the Norwich Research Park in the United Kingdom. Housing the Institute of Food Research, the multidisciplinary project is being created in partnership with Norwich University Hospital and will accommodate the study of gut flora in the human microbiome, healthy aging, and food innovation and safety.

SoBran BioScience is creating an animal research facility in Greensboro, N.C. Located on the north campus of the Gateway University Research Park, the laboratory and office building will support collaborative partnerships with North Carolina Agricultural and Technical State University. The facility will provide 8,500 sf of preclinical lab space designed to meet ISO 9001-2008 and GLP (Good Laboratory Practice) standards and attain full AAALAC accreditation.

The University of Cambridge is planning to build a $125 million biomedical research facility in the United Kingdom. The six-story, 190,000-sf Project Capella will house the Cambridge Stem Cell Institute, the Milner Therapeutics Institute, the Cambridge Institute of Therapeutic Immunology & Infectious Disease, and the Cambridge Centre for Haematopoiesis and Haematological Malignancies. Lean construction methodology will be implemented in the delivery of the facility, which is slated for completion in the second quarter of 2018.